About Oncode Accelerator
The current process to develop cancer therapies is expensive, time-consuming and high-risk. More importantly, newly developed therapies are often only effective in a small group of the intended patient population.
The medical, financial, and societal burden of the disease is growing, and so is the demand for effective, safe and personalized treatments. Preclinical development is a crucial step in advancing a new cancer therapy towards clinical application. However, too many of the innovations that make it through the preclinical development process fail in late-stage clinical trials. Therefore, there is a clear need to increase the likelihood of success.
To truly make a difference in the lives of cancer patients, the preclinical development process needs to be revolutionized. Oncode Accelerator is taking on this challenge, driven by a profound commitment to improving patient outcomes. Our novel approach will allow for earlier predictions of cancer therapy effectiveness and safety, leading to a significantly faster process and better patient outcomes.
